MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MPW - US58463J3041 - REIT
5.3 USD
+0.27 (+5.37%)
5.33 USD
+0.03 (+0.57%)
We assign a fundamental rating of 3 out of 10 to MPW. MPW was compared to 128 industry peers in the Diversified REITs industry. There are concerns on the financial health of MPW while its profitability can be described as average. MPW is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MPW had negative earnings in the past year.
In the past year MPW had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
Each year in the past 5 years MPW had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -4.74%, MPW is not doing good in the industry: 82.03% of the companies in the same industry are doing better.
MPW has a worse Return On Equity (-15.19%) than 78.13% of its industry peers.
The Return On Invested Capital of MPW (2.76%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for MPW is in line with the industry average of 3.06%.
The 3 year average ROIC (2.26%) for MPW is below the current ROIC(2.76%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.74% | ||
| ROE | -15.19% | ||
| ROIC | 2.76% |
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
1.3 Margins
The Operating Margin of MPW (53.48%) is better than 95.31% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 96.07%, MPW belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 53.48% | ||
| PM (TTM) | N/A | ||
| GM | 96.07% |
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
2. Health
2.1 Basic Checks
MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MPW has more shares outstanding
MPW has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MPW has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.02, we must say that MPW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MPW (0.02) is worse than 73.44% of its industry peers.
MPW has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.06, MPW is doing worse than 71.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.02 |
ROIC/WACC0.46
WACC6.06%
2.3 Liquidity
MPW has a Current Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MPW (2.00) is better than 80.47% of its industry peers.
MPW has a Quick Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 2.00, MPW belongs to the best of the industry, outperforming 80.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
MPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.50%, which is quite impressive.
The Revenue has grown by 45.56% in the past year. This is a very strong growth!
MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
3.2 Future
The Earnings Per Share is expected to grow by 27.84% on average over the next years. This is a very strong growth
MPW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 34.07, the valuation of MPW can be described as expensive.
Based on the Price/Forward Earnings ratio, MPW is valued a bit cheaper than the industry average as 71.09% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.42, MPW is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.07 |
4.2 Price Multiples
MPW's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MPW is more expensive than 60.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.14 |
4.3 Compensation for Growth
MPW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MPW's earnings are expected to grow with 27.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.49%
EPS Next 3Y27.84%
5. Dividend
5.1 Amount
MPW has a Yearly Dividend Yield of 7.16%, which is a nice return.
MPW's Dividend Yield is a higher than the industry average which is at 6.59.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.16% |
5.2 History
The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-27.26%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
5.3
+0.27 (+5.37%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners59.4%
Inst Owner Change-3.05%
Ins Owners17.29%
Ins Owner Change-2.04%
Market Cap3.19B
Revenue(TTM)933.52M
Net Income(TTM)-707.95M
Analysts51.76
Price Target5.1 (-3.77%)
Short Float %31.08%
Short Ratio17.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.16% |
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-27.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-873.24%
Min EPS beat(2)-1816.17%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3643.79%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-2173.83%
EPS beat(12)2
Avg EPS beat(12)-1482.28%
EPS beat(16)6
Avg EPS beat(16)-1094.33%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.7%
Max Revenue beat(2)2.15%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.69%
Revenue beat(16)7
Avg Revenue beat(16)-1.26%
PT rev (1m)2.94%
PT rev (3m)1.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-230.13%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.07 | ||
| P/S | 3.41 | ||
| P/FCF | N/A | ||
| P/OCF | 21.62 | ||
| P/B | 0.68 | ||
| P/tB | 0.68 | ||
| EV/EBITDA | 16.14 |
EPS(TTM)-1
EYN/A
EPS(NY)0.16
Fwd EY2.93%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.25
OCFY4.63%
SpS1.55
BVpS7.75
TBVpS7.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.74% | ||
| ROE | -15.19% | ||
| ROCE | 3.49% | ||
| ROIC | 2.76% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 2.95% | ||
| OM | 53.48% | ||
| PM (TTM) | N/A | ||
| GM | 96.07% | ||
| FCFM | N/A |
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 12.51 | ||
| Cap/Depr | 69.46% | ||
| Cap/Sales | 20.04% | ||
| Interest Coverage | 1.08 | ||
| Cash Conversion | 19.18% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 0.02 |
F-Score5
WACC6.06%
ROIC/WACC0.46
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%
EBIT growth 1Y1889.1%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.92%
EBIT Next 3Y37.51%
EBIT Next 5Y20.65%
FCF growth 1Y70.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.27%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%
MEDICAL PROPERTIES TRUST INC / MPW FAQ
What is the fundamental rating for MPW stock?
ChartMill assigns a fundamental rating of 3 / 10 to MPW.
What is the valuation status for MPW stock?
ChartMill assigns a valuation rating of 2 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.
Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?
MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 4 / 10.
What is the financial health of MEDICAL PROPERTIES TRUST INC (MPW) stock?
The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 2 / 10.
Can you provide the expected EPS growth for MPW stock?
The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 90.15% in the next year.